| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.3 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |